Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00562263 · ClinicalTrials.gov registry record · NA

Barriers to Effective Weight Loss in Overweight Adolescents

A NA study of Overweight, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
257
Enrollment target
1
Study location

NCT00562263: Completed NA study of Overweight, sponsored by Virginia Commonwealth University.

NCT00562263 is a NA study of Overweight that has completed, run by Virginia Commonwealth University. The registered enrollment target is 257 participants, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00562263, a NA study of Overweight, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
257 participants
Enrollment target
1
Study location

Study Summary

The current study aims to investigate the impact of a comprehensive, team-based, family-centered, lifestyle modification program on body weight, metabolic abnormalities, fitness measures, and self-esteem in overweight adolescents beginning the study at ages 11-18 years. The intensive program will uniquely include a "team" structure and a component designed to address the role of parental modeling in effective lifestyle changes. By comparing the demographic, psychosocial, and metabolic characteristics of adolescents according to the degree of weight loss, the study will also more fully characterize the barriers that prevent successful participation in an intensive lifestyle modification program.

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle modification

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 257 participants
Start Date 2007-10
Est. Completion 2013-11
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT00562263 record still lists

NCT00562263 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle modification is the first listed.

NCT00562263 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT00562263 about?

NCT00562263 is a clinical study titled "Barriers to Effective Weight Loss in Overweight Adolescents". The current study aims to investigate the impact of a comprehensive, team-based, family-centered, lifestyle modification program on body weight, metabolic abnormalities, fitness measures, and self-esteem in overweight adolescents beginning the study at ages 11-18 years. The intensive program will un...

What is the current status of trial NCT00562263?

This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2007-10. Estimated completion is 2013-11.

What conditions does trial NCT00562263 study?

This clinical trial studies the following conditions: Overweight.

What interventions are being tested in trial NCT00562263?

The interventions under investigation include: Lifestyle modification (BEHAVIORAL).

Who is sponsoring clinical trial NCT00562263?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00562263 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00562263's enrollment target sits among peer trials

257 62nd of 197 higher than 136 of 197 other Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03618550 · 257 participants · Phase 2

    Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

  • NCT04674267 · 257 participants · NA

    Resilience and Equity in Aging, Cancer, and Health (REACH)

  • NCT06099288 · 257 participants · NA

    Strong Families Start at Home/Familias Fuertes Comienzan en Casa

  • NCT06207084 · 257 participants · NA

    The Fit With Us Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00562263, the US trial registry maintained by the National Library of Medicine. NCT00562263 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.